Avalo Therapeutics (NASDAQ:AVTX) Now Covered by Piper Sandler
Piper Sandler began coverage on shares of Avalo Therapeutics (NASDAQ:AVTX – Get Free Report) in a research note issued on Friday, MarketBeat reports. The firm set an “overweight” rating and a $48.00 price target on the stock. Other analysts also recently issued research reports about the stock. Wedbush began coverage on shares of Avalo Therapeutics […]
Piper Sandler began coverage on shares of Avalo Therapeutics (NASDAQ:AVTX – Get Free Report) in a research note issued on Friday, MarketBeat reports. The firm set an “overweight” rating and a $48.00 price target on the stock. Other analysts also recently issued research reports about the stock. Wedbush began coverage on shares of Avalo Therapeutics […]
